Cornerstone's Strategic Transaction with Chiesi
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 5 (Table of Contents)
Published: 27 May-2009
DOI: 10.3833/pdr.v2009.i5.1114 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Cornerstone gains an exclusive 10 year license for US commercial rights to the marketed respiratory drug, Curosurf, and receives cash proceeds of US$15...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS